The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations

Worldwide, hypertension is the leading risk factor for cardiovascular disease and death. An estimated 122 million people, per the American Heart Association in 2023, have been diagnosed with this common condition. It is generally agreed that the primary goal in the treatment of hypertension is to re...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Kamryn E. Jones, Shaun L. Hayden, Hannah R. Meyer, Jillian L. Sandoz, William H. Arata, Kylie Dufrene, Corrado Ballaera, Yair Lopez Torres, Patricia Griffin, Adam M. Kaye, Sahar Shekoohi, Alan D. Kaye
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-06-01
Saila:	Current Issues in Molecular Biology
Gaiak:	calcium channel blocker hypertension angiotensin-converting enzyme inhibitors angiotensin receptor blockers
Sarrera elektronikoa:	https://www.mdpi.com/1467-3045/46/7/377
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!